Finance

Lists
NXGN:TLV
Nextgen Biomed Ltd
ILA 45.00
0.00%
(0.00) 1D
May 20, 5:24:52 PM GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for NXGN...
Mkt. cap
10.11M
Avg. vol.
0.00
Volume
0.00
52-wk high
ILA 62.00
52-wk low
ILA 37.60
Shares outstanding
22.48M
No. of employees
3
Mkt. cap
10.11M
Avg. vol.
0.00
Volume
0.00
52-wk high
ILA 62.00
52-wk low
ILA 37.60
Shares outstanding
22.48M
No. of employees
3
News stories
From web sources and news partners
About Nextgen Biomed Ltd
CEO-
Employees3
Founded1990
Headquarters-
SectorPharmaceutical industry
Websitenextgen-biomed.com
Previous reportsAll values in ILS
Loading Previous Earnings...
Revenue
Net income
All values in ILS
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
231.00K
231.00K
146.50K
146.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.23M
1.23M
816.50K
816.50K
Operating expense
1.60M
1.60M
3.71M
3.71M
Total operating expenses
1.60M
1.60M
3.71M
3.71M
Operating income
-1.60M
-1.60M
-3.71M
-3.71M
Other non operating income
-
-
-
-
EBT including unusual items
-1.59M
-1.59M
-3.85M
-3.85M
EBT excluding unusual items
-1.59M
-1.59M
-3.85M
-3.85M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
131.50K
131.50K
2.75M
2.75M
Net income
-1.59M
-1.59M
-3.18M
-3.18M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2.00K
2.00K
15.00K
15.00K
Interest expense
-500.00
-500.00
-149.50K
-149.50K
Net interest expenses
1.50K
1.50K
-134.50K
-134.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.56M
-1.56M
-3.67M
-3.67M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps